Kopran Share Price

194.019.23 (5.00%)

Closed
As On: 19 Jun, 2026, 03:50 PM IST
As On: 19 Jun, 2026, 03:50 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	187.00
High	194.01
Low	187.00
Prev Close	184.78
Volume	1,70,382
VWAP(₹)	193.23

Share Price	Value
Today/Current/Last	194.01194.60
Previous Day	184.78185.35

Kopran Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

Madhusudan Kela picks beaten-down smallcap bets; buys Indiabulls, Simplex Infra in Q4
News
Madhusudan Kela bites this crunchy pick in Mar quarter, adds 2 more smallcaps to his Rs 3,500 cr portfolio
News
These 5 stocks hit 52-week lows, fell up to 30% in a month
News
Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting
Announcements

View all Kopran Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	234.11	194.35	117.93	137.77	175.62
Total Income Growth (%)	20.46	64.79	-14.40	-21.55	5.53
Total Expenses	205.59	180.93	127.47	125.34	159.15
Total Expenses Growth (%)	13.63	41.94	1.69	-21.24	5.81
EBIT	28.52	13.41	-9.53	12.43	16.48
EBIT Growth (%)	112.61	-	-176.71	-24.59	2.90
Profit after Tax (PAT)	18.87	9.34	-9.92	7.45	9.68
PAT Growth (%)	101.99	-	-233.21	-23.02	-6.91
EBIT Margin (%)	12.18	6.90	-8.08	9.02	9.38
Net Profit Margin (%)	8.06	4.81	-8.41	5.41	5.51
Basic EPS (₹)	3.91	1.93	-2.06	2.01	2.01

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	119.04	94.20	42.71	53.13	77.85
Total Income Growth (%)	26.37	120.55	-19.61	-31.75	7.11
Total Expenses	92.80	77.46	46.76	47.48	64.89
Total Expenses Growth (%)	19.80	65.66	-1.52	-26.82	4.87
EBIT	26.25	16.74	-4.05	5.65	12.97
EBIT Growth (%)	56.75	-	-171.60	-56.43	19.91
Profit after Tax (PAT)	18.74	12.13	-3.99	3.52	8.60
PAT Growth (%)	54.52	-	-213.51	-59.09	16.10
EBIT Margin (%)	22.05	17.77	-9.47	10.63	16.66
Net Profit Margin (%)	15.75	12.88	-9.35	6.62	11.05
Basic EPS (₹)	3.88	2.51	-0.83	0.73	1.78

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	681.77	633.59	629.20	554.05	488.13
Total Revenue Growth (%)	7.60	0.70	13.56	13.51	-4.25
Total Expenses	647.41	581.64	561.66	517.99	406.35
Total Expenses Growth (%)	11.31	3.56	8.43	27.47	-4.72
Profit after Tax (PAT)	25.73	38.55	50.96	27.23	61.03
PAT Growth (%)	-33.26	-24.34	87.11	-55.38	-0.93
Operating Profit Margin (%)	6.57	9.73	12.38	7.64	18.19
Net Profit Margin (%)	3.77	6.12	8.29	4.94	12.78
Basic EPS (₹)	5.33	7.99	10.57	5.65	13.77

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	307.65	276.91	354.17	289.18	212.55
Total Revenue Growth (%)	11.10	-21.81	22.47	36.05	-8.87
Total Expenses	267.25	241.12	309.65	252.27	196.38
Total Expenses Growth (%)	10.84	-22.13	22.75	28.46	-2.07
Profit after Tax (PAT)	30.40	26.86	34.64	31.25	11.74
PAT Growth (%)	13.19	-22.46	10.83	166.11	-49.97
Operating Profit Margin (%)	14.58	14.59	14.52	14.49	9.34
Net Profit Margin (%)	9.94	9.90	10.26	11.44	5.74
Basic EPS (₹)	6.30	5.57	7.18	6.48	2.65

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent 1.54% of its operating revenues towards interest expenses and 9.57% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	908.36	844.01	743.25	649.70	610.89
Total Assets Growth (%)	7.62	13.56	14.40	6.35	39.03
Total Liabilities	378.08	325.66	252.00	210.45	184.72
Total Liabilities Growth (%)	16.10	29.23	19.74	13.93	-4.96
Total Equity	530.28	518.35	491.25	439.25	426.17
Total Equity Growth (%)	2.30	5.52	11.84	3.07	73.92
Current Ratio (x)	1.51	1.76	2.08	2.25	2.74
Total Debt to Equity (x)	0.29	0.29	0.20	0.17	0.17
Contingent Liabilities	0.00	24.84	25.81	19.87	47.91

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	605.89	546.48	510.88	505.95	464.12
Total Assets Growth (%)	10.87	6.97	0.97	9.01	43.27
Total Liabilities	158.06	115.05	94.01	110.36	85.40
Total Liabilities Growth (%)	37.38	22.38	-14.82	29.23	10.77
Total Equity	447.83	431.44	416.87	395.59	378.72
Total Equity Growth (%)	3.80	3.50	5.38	4.45	53.42
Current Ratio (x)	1.63	2.02	2.22	1.89	1.98
Total Debt to Equity (x)	0.10	0.11	0.05	0.07	0.10
Contingent Liabilities	0.00	64.56	57.76	48.11	45.45

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	66.75	41.94	43.26	34.02	-33.48
Net Cash used in Investing Activities	-64.60	-56.43	-43.55	-12.65	-84.42
Net Cash flow from Financing Activities	-20.94	25.87	0.99	-19.84	122.82
Net Cash Flow	-18.79	11.38	0.69	1.53	4.93
Closing Cash & Cash Equivalent	0.68	19.47	8.09	7.40	5.87
Closing Cash & Cash Equivalent Growth (%)	-96.50	140.67	9.39	26.04	224.70
Total Debt/ CFO (x)	2.29	3.52	2.29	2.21	-2.17

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	29.66	23.30	34.96	16.87	-37.81
Net Cash used in Investing Activities	-30.08	-15.41	-6.27	10.05	-100.26
Net Cash flow from Financing Activities	-18.53	5.64	-24.08	-26.13	138.00
Net Cash Flow	-18.95	13.53	4.61	0.79	-0.07
Closing Cash & Cash Equivalent	0.22	19.18	5.65	1.04	0.25
Closing Cash & Cash Equivalent Growth (%)	-98.83	239.56	444.57	312.65	-22.53
Total Debt/ CFO (x)	1.56	1.94	0.65	1.65	-0.97

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 64.6 cr for investing activities which is an YoY increase of 14.48%. (Source: Consolidated Financials)

View Details

Ratios

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	4.85	7.43	10.37	6.19	14.32
Return on Capital Employed (%)	7.97	11.04	14.51	8.91	18.91
Return on Assets (%)	2.83	4.56	6.85	4.19	9.99
Interest Coverage Ratio (x)	5.95	8.23	10.36	9.02	19.15
Asset Turnover Ratio (x)	0.78	0.79	0.88	0.87	0.45
Price to Earnings (x)	20.28	21.98	24.45	19.57	22.27
Price to Book (x)	0.98	1.63	2.54	1.21	3.19
EV/EBITDA (x)	10.70	12.58	14.95	10.85	14.01
EBITDA Margin (%)	9.14	12.21	14.48	9.95	20.52

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	6.78	6.22	8.30	7.90	3.10
Return on Capital Employed (%)	9.71	8.92	11.49	9.77	4.92
Return on Assets (%)	5.01	4.91	6.77	6.17	2.53
Interest Coverage Ratio (x)	11.80	11.83	11.92	16.47	7.94
Asset Turnover Ratio (x)	0.53	0.51	0.66	0.56	0.52
Price to Earnings (x)	17.15	31.55	35.97	17.06	116.28
Price to Book (x)	1.16	1.96	2.99	1.35	3.58
EV/EBITDA (x)	11.40	19.52	23.51	12.68	59.37
EBITDA Margin (%)	16.21	16.44	15.89	16.11	11.46

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Kopran Ltd	36.41	1.77	4.85	7.97	2.83	7.09	6.57	3.77	5.33	1.51	0.29	2.29
Lincoln Pharma	14.01	1.62	11.60	14.96	9.87	9.66	17.38	13.09	43.88	5.25	0.01	0.04
Bajaj Healthcare	66.82	1.98	2.95	14.28	1.70	-2.86	13.81	2.58	4.98	1.92	0.44	4.02
Fermenta Biotech	13.67	2.48	17.86	22.88	11.20	15.11	19.13	13.37	24.70	1.86	0.27	1.17
Themis Medicare	819.07	2.35	0.28	-0.13	0.19	-1.30	-0.16	-3.77	0.12	1.84	0.25	-30.65
Add More

Annual Ratios (%)

Choose from Peers

Wanbury Ltd
Anuh Pharma
Kilitch Drug
Zim Laboratories
Praveg Comm

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Kopran Ltd Stock Performance	5.00	22.85	27.03	49.26	0.98	31.18	1.44
Lincoln Pharma Stock Performance	0.97	-7.72	1.07	-1.28	1.50	39.30	87.77
Bajaj Healthcare Stock Performance	-1.31	6.57	-4.75	-11.23	-44.32	2.66	0.00
Fermenta Biotech Stock Performance	5.78	15.68	6.79	0.00	0.00	0.00	0.00
Themis Medicare Stock Performance	-0.08	2.57	10.31	12.27	-28.53	-35.26	105.56
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	2,14,49,203	44.42 %	0.00
Pledge	0	0.00 %	0.00
FII	2,75,051	0.57 %	0.21
DII	1,604	0.00 %	0.00
MF	1,604	0.00 %	0.00
Others	2,65,59,747	55.01 %	-0.21

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	44.42	44.42	44.42	44.42
Pledge	0.00	0.00	0.00	0.00
FII	0.57	0.36	0.60	0.76
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	55.01	55.22	54.98	54.82

Mutual Funds Ownership

MF Ownership as on 31 May 2026

Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.01
  Amount Invested (in Cr.)
- 0.04%
  % of AUM
- -9.57
  % Change (MoM basis)
Bandhan BSE Healthcare Index Direct-G
Equity: Sectoral-Pharma
- 0.01
  Amount Invested (in Cr.)
- 0.04%
  % of AUM
- 6.67
  % Change (MoM basis)

View all Mutual Fund Schemes

Corporate Actions

Recent
General Meeting
-
May 19, 2026
Final
30%
May 19, 2026
Board Meeting
Audited Results & Final Dividend
May 06, 2026

Board Meetings

Announced on	Meeting on
May 06, 2026	May 19, 2026
Audited Results & Final Dividend
Jan 13, 2026	Jan 22, 2026
Quarterly Results
Oct 30, 2025	Nov 12, 2025
Quarterly Results
Jul 18, 2025	Jul 29, 2025
Quarterly Results
May 07, 2025	May 15, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
May 15, 2025 Sep 04, 2025 30%
May 16, 2024 Sep 02, 2024 30%
May 25, 2023 Sep 07, 2023 30%
May 27, 2022 Aug 04, 2022 30%
May 19, 2026 - 30%
Bonus
Announced on Ex-Date
Mar 25, 1994 Apr 08, 1994
Bonus Ratio: 1 share(s) for every 2 shares held
Splits
No Data Available
Rights
Announced on Ex-Date
Dec 24, 2001 Mar 13, 2002
Rights ratio: 1 share for every 2 held at a price of Rs 40.0
Feb 18, 1999 Feb 22, 1999
NA
AGM/EGM Meetings
Announced on Meeting on
May 19, 2026 Aug 18, 2026
-
Apr 30, 2026 Jun 03, 2026
-
Aug 20, 2025 Sep 11, 2025
-
Jul 23, 2024 Sep 05, 2024
Dividend - Rs 3 Per Share
May 16, 2024 Sep 11, 2024
-

Announced on	Ex-Date	Dividend%
May 15, 2025	Sep 04, 2025	30%
May 16, 2024	Sep 02, 2024	30%
May 25, 2023	Sep 07, 2023	30%
May 27, 2022	Aug 04, 2022	30%
May 19, 2026	-	30%

Announced on	Ex-Date
Mar 25, 1994	Apr 08, 1994
Bonus Ratio: 1 share(s) for every 2 shares held

Announced on	Ex-Date
Dec 24, 2001	Mar 13, 2002
Rights ratio: 1 share for every 2 held at a price of Rs 40.0
Feb 18, 1999	Feb 22, 1999
NA

Announced on	Meeting on
May 19, 2026	Aug 18, 2026
-
Apr 30, 2026	Jun 03, 2026
-
Aug 20, 2025	Sep 11, 2025
-
Jul 23, 2024	Sep 05, 2024
Dividend - Rs 3 Per Share
May 16, 2024	Sep 11, 2024
-

About Kopran

Kopran Ltd., incorporated in the year 1958, is a Small Cap company (having a market cap of Rs 936.79 Crore) operating in Pharmaceuticals sector.

Kopran Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Scrap for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 234.11 Crore, up 20.46 % from last quarter Total Income of Rs 194.35 Crore and up 33.30 % from last year same quarter Total Income of Rs 175.62 Crore. Company has reported net profit after tax of Rs 18.87 Crore in latest quarter.

The company’s top management includes Mr.Susheel G Somani, Mr.Surendra Somani, Mrs.Mamta Biyani, Mr.Narayan Atal, Dr.Siddhan Subramanian, Dr.Sunita Banerji, Mr.Adarsh Somani, Mr.Varun Somani, Mr.Basant K Soni, Mr.Sunil Sodhani. Company has Khandelwal Jain & Co. as its auditors. As on 31-03-2026, the company has a total of 4.83 Crore shares outstanding.

Kopran Ltd Share Price Today is Rs. 194.01. On previous day, the Kopran Ltd Share Price (NSE) closed at Rs. 184.78, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 44.42% of the stake in Kopran Ltd shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Kopran Ltd stocks was 0.57% as compared to 0.36% in Dec 2025 with increase of 0.21%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with decrease of 0.0%. Out of the total DII holdings in Kopran Ltd shares 0.0% was held by mutual funds. The rest including public held is 55.01%. Kopran Ltd stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Kopran Ltd Dividend: Ever since 1958, Kopran Ltd dividends has been paid out around 14 times. As on 19 Jun, 2026, 03:50 PM IST, The overall dividend yield for Kopran Ltd stands at 1.62%. The last dividend paid was on September 4, 2025 (Rs. 3.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 5.33.

Kopran Ltd Bonus: The most recent bonus issue had been in year April 8, 1994 around 32 years ago at 2 : 1 ratio. The first bonus issue was announced in Mar 1994.

Stock Forecast:
After showing 234.11 Cr. of sales and 20.46% of quarterly net profit, there have been multiple ups and downs in the Kopran Ltd stock prices in the past few weeks. For example, Kopran Ltd stock price on 12th of June 2026 was around Rs. 181.64. Kopran Ltd share price now stands at an average of Rs. 194.01. Judging by last week's performance, stock is in up trend.

Kopran Ltd has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Kopran Ltd share.

Historical Prices and Performance:
Kopran Ltd, incorporated in 1958 is a Small Cap company (with a market cap of Rs. 936.79) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Kopran Ltd stock was 4.85%, 7.43%, 10.37%, 6.19% and 14.32% respectively.
The Kopran Ltd share gave a 3 year return of 7.69% as compared to Nifty 50 which gave a return of 28.03%.
Kopran Ltd announced 30.0% final dividend on September 4, 2025.

Key Metrics:
PE Ratio of Kopran Ltd is 34.67
Prices/Sales Ratio of Kopran Ltd is 0.76
Price/Book Ratio of Kopran Ltd is 1.68

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Kopran Ltd, major competitors and peers include Lincoln Pharma, Bajaj Healthcare, Fermenta Biotech and Themis Medicare. As of Dec 2025, the dividend yield of Kopran Ltd stands at 1.62% while Lincoln Pharma, Bajaj Healthcare, Fermenta Biotech and Themis Medicare stand at 0.0%, 0.48%, 1.11% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 34.67 and 1.68 respectively.

Leadership of Kopran Ltd :
Sunil Sodhani is Co. Secretary & Compl. Officer
Basant K Soni is Chief Financial Officer
Susheel G Somani is Chairman
Surendra Somani is Executive Vice Chairman
Adarsh Somani is Director
Varun Somani is Director
Siddhan Subramanian is Independent Director
Sunita Banerji is Independent Director
Mamta Biyani is Independent Director
Narayan Atal is Independent Director

Industry

Pharma - Indian

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, BSE MidSmallCap

Address

Parijat House,1076, Dr. E. Moses Road,Worli,Mumbai, Maharashtra - 400018

Contact

investors@kopran.com

http://www.kopran.com

PE Ratio(x)	36.41
EPS - TTM(₹)	5.33
MCap(₹ Cr.)	936.79
MCap Rank	90
PB Ratio(x)	1.68
Div Yield(%)	1.55
Face Value(₹)	10.00
52W High(₹)	219.00
52W Low(₹)	107.00
MCap/Sales	0.76
Beta(1 Month)	2.67
BV/Share(₹)	109.82

PE Ratio(x)	36.52
EPS - TTM(₹)	5.33
MCap(₹ Cr.)	939.64
MCap Rank	91
PB Ratio(x)	1.69
Div Yield(%)	1.54
Face Value(₹)	10.00
52W High(₹)	218.90
52W Low(₹)	107.00
MCap/Sales	0.76
Beta(1 Month)	2.62
BV/Share(₹)	109.82

1 Day	5.0%
1 Month	12.64%
3 Months	69.65%
1 Year	4.83%
3 Years	7.69%
5 Years	-2.68%

1 Day	4.99%
1 Month	12.98%
3 Months	71.15%
1 Year	5.1%
3 Years	7.75%
5 Years	-2.26%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Kopran Share Price

Key Metrics

Kopran Ltd share price insights

Kopran Ltd Share Price Returns

Kopran Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Motilal Oswal BSE Healthcare ETF-G

Bandhan BSE Healthcare Index Direct-G

Kopran Ltd Top Searches

Corporate Actions

About Kopran

Executive Leadership

Auditors

FAQs about Kopran share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News